Journal profile · Rheumatology
Clinical and Experimental Rheumatology
ISSN 0392-856X · eISSN 1593-098X · Clinical and Experimental Rheumatology S.A.S. · ITALY · Bimonthly
Clinical and Experimental Rheumatology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.17; subscription journal; APC charged, amount not published; median 81 days to acceptance (102 articles, last 24 months); community-reported acceptance: easy; 332 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical and Experimental Rheumatology is published by Clinical and Experimental Rheumatology S.A.S. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments and Systemic Sclerosis and Related Diseases, together about 33.5% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)
Clinical and Experimental Rheumatology is a monthly international peer-reviewed journal which has been covering all clinical, experimental and translational aspects of musculoskeletal, arthritic and connective tissue diseases since 1983.
From the journal's Aims & Scope
Research area (LetPub): Rheumatology
Editor-in-chief Stefano BombardieriPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Rheumatoid Arthritis Research and TherapiesMedicine15.7%
- Spondyloarthritis Studies and TreatmentsMedicine9%
- Systemic Sclerosis and Related DiseasesMedicine8.8%
- Systemic Lupus Erythematosus ResearchMedicine8.3%
- Inflammatory Myopathies and DermatomyositisMedicine7.6%
- Vasculitis and related conditionsMedicine7.4%
- Salivary Gland Disorders and FunctionsMedicine4.9%
- Autoimmune and Inflammatory Disorders ResearchMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Rheumatology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Rheumatology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.17LetPub ·
- CiteScore 2026-06
- 5.8LetPub ·
- SJR 2026-06
- 1.04LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 87LetPub ·
- h-index
- 40OpenAlex ·
- i10-index
- 470OpenAlex ·
- 2-year mean citedness
- 1.28OpenAlex ·
- Self-citation rate
- 18.8%LetPub ·
- Share of gold OA articles
- 1.53%LetPub ·
Volume
- Articles per year
- 238LetPub ·
Articles by year OpenAlex count · 2,292 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 131 | 41 | 7 |
| 2025 | 332 | 159 | 251 |
| 2024 | 319 | 255 | 740 |
| 2023 | 308 | 229 | 1,466 |
| 2022 | 433 | 308 | 3,950 |
| 2021 | 556 | 395 | 6,710 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
81 daysMedian, submission to acceptance · P25–P75 57 days – 124 days
- Acceptance to online
- median 48 days (102 articles)
- Submission to online
- median 158 days
- Sample
- 102 articles with submission and acceptance dates (727 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–6 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | EUR 150 / EUR 300 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Clinical and Experimental Rheumatology S.A.S.
- Country or region
- ITALY
- Language
- English
- Frequency
- Bimonthly
- ISSN
- 0392-856X
- Electronic ISSN
- 1593-098X
- Society / sponsor
- International Myositis Society
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Clinical and Experimental Rheumatology
What CAS zone is Clinical and Experimental Rheumatology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical and Experimental Rheumatology is in Zone 3 of Medicine, and in Zone 3 of the minor category Rheumatology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical and Experimental Rheumatology?
The latest impact factor listed by LetPub is 3.17; CiteScore 5.8, h-index 40.
How long does peer review take at Clinical and Experimental Rheumatology?
Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 81 days (interquartile range 57–124 days); authors report an average review time of 3–6 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Clinical and Experimental Rheumatology?
According to LetPub and DOAJ records, Clinical and Experimental Rheumatology is indexed in SCIE and Scopus.
Is Clinical and Experimental Rheumatology open access, and what is the APC?
Clinical and Experimental Rheumatology is a subscription journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .